714 related articles for article (PubMed ID: 10517679)
1. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.
Solow BT; Harada S; Goldstein BJ; Smith JA; White MF; Jarett L
Mol Endocrinol; 1999 Oct; 13(10):1784-98. PubMed ID: 10517679
[TBL] [Abstract][Full Text] [Related]
2. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
3. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation.
Harada S; Smith RM; Smith JA; White MF; Jarett L
J Biol Chem; 1996 Nov; 271(47):30222-6. PubMed ID: 8939974
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
Thirone AC; Carvalho CR; Saad MJ
Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
Kim B; Leventhal PS; White MF; Feldman EL
Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
[TBL] [Abstract][Full Text] [Related]
7. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin enhances insulin receptor tyrosine kinase in 32D cells reconstituted with bradykinin and insulin signaling pathways.
Motoshima H; Araki E; Nishiyama T; Taguchi T; Kaneko K; Hirashima Y; Yoshizato K; Shirakami A; Sakai K; Kawashima J; Shirotani T; Kishikawa H; Shichiri M
Diabetes Res Clin Pract; 2000 Jun; 48(3):155-70. PubMed ID: 10802154
[TBL] [Abstract][Full Text] [Related]
9. Combination of insulinomimetic agents H2O2 and vanadate enhances insulin receptor mediated tyrosine phosphorylation of IRS-1 leading to IRS-1 association with the phosphatidylinositol 3-kinase.
Wilden PA; Broadway D
J Cell Biochem; 1995 Jul; 58(3):279-91. PubMed ID: 7593251
[TBL] [Abstract][Full Text] [Related]
10. Effect of nutritional state on the formation of a complex involving insulin receptor IRS-1, the 52 kDa Src homology/collagen protein (Shc) isoform and phosphatidylinositol 3'-kinase activity.
Dupont J; Derouet M; Simon J; Taouis M
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):293-300. PubMed ID: 9761726
[TBL] [Abstract][Full Text] [Related]
11. Morphine induces desensitization of insulin receptor signaling.
Li Y; Eitan S; Wu J; Evans CJ; Kieffer B; Sun X; Polakiewicz RD
Mol Cell Biol; 2003 Sep; 23(17):6255-66. PubMed ID: 12917346
[TBL] [Abstract][Full Text] [Related]
12. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
13. Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphoinositide 3-kinase activation alone is not sufficient for the mediation of insulin's metabolic and mitogenic effects.
Krook A; Whitehead JP; Dobson SP; Griffiths MR; Ouwens M; Baker C; Hayward AC; Sen SK; Maassen JA; Siddle K; Tavaré JM; O'Rahilly S
J Biol Chem; 1997 Nov; 272(48):30208-14. PubMed ID: 9374504
[TBL] [Abstract][Full Text] [Related]
14. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
[TBL] [Abstract][Full Text] [Related]
15. Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart.
Laviola L; Belsanti G; Davalli AM; Napoli R; Perrini S; Weir GC; Giorgino R; Giorgino F
Diabetes; 2001 Dec; 50(12):2709-20. PubMed ID: 11723053
[TBL] [Abstract][Full Text] [Related]
16. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors.
Inoue G; Cheatham B; Kahn CR
J Biol Chem; 1996 Nov; 271(45):28206-11. PubMed ID: 8910437
[TBL] [Abstract][Full Text] [Related]
17. UV activation of receptor tyrosine kinase activity.
Coffer PJ; Burgering BM; Peppelenbosch MP; Bos JL; Kruijer W
Oncogene; 1995 Aug; 11(3):561-9. PubMed ID: 7543196
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
Dey BR; Frick K; Lopaczynski W; Nissley SP; Furlanetto RW
Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723
[TBL] [Abstract][Full Text] [Related]
19. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
20. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation.
Noguchi T; Matozaki T; Horita K; Fujioka Y; Kasuga M
Mol Cell Biol; 1994 Oct; 14(10):6674-82. PubMed ID: 7935386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]